TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TFFP

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/18	05 : 07	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2024/05/18	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2024/05/15	05 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2024/05/15	05 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2024/05/07	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/19	20 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/16	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/13	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/09	06 : 52	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/09	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/05	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/05	07 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/12/05	07 : 25	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/11/23	07 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/11/22	06 : 41	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/11/15	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/10/05	05 : 10	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/10/05	05 : 07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/10/05	05 : 07	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/09/23	05 : 16	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/09/19	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/09/19	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/18	05 : 01	GlobeNewswire Inc.	TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/17	05 : 43	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	21 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	21 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	19 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	19 : 00	GlobeNewswire Inc.	TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	05 : 12	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TFFP	TFF Pharmaceuticals Inc
2023/08/15	05 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TFFP	TFF Pharmaceuticals Inc